BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23740063)

  • 21. Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome.
    Mauss S; Berger F; Schober A; Moog G; Heyne R; John C; Pape S; Hueppe D; Pfeiffer-Vornkahl H; Alshuth U
    J Viral Hepat; 2013 Apr; 20(4):e72-7. PubMed ID: 23490392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
    Ferri S; Muratori L; Quarneti C; Muratori P; Menichella R; Pappas G; Granito A; Ballardini G; Bianchi FB; Lenzi M
    J Hepatol; 2009 Jun; 50(6):1093-101. PubMed ID: 19398235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.
    Ramos-Casals M; Pares A; Jara LJ; Solans R; Viñas O; Vázquez P; Sánchez-Tapias JM; Rodés J; Font J;
    J Viral Hepat; 2005 Nov; 12(6):648-54. PubMed ID: 16255767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-C1q antibodies in hepatitis C virus infection.
    Saadoun D; Sadallah S; Trendelenburg M; Limal N; Sene D; Piette JC; Schifferli JA; Cacoub P
    Clin Exp Immunol; 2006 Aug; 145(2):308-12. PubMed ID: 16879251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies.
    Garrido Palma G; Sánchez Cuenca JM; Olaso V; Pina R; Urquijo JJ; López Viedma B; Bustamante M; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1999 Mar; 91(3):168-81. PubMed ID: 10231308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies in HCV infected patients at Sharkia Governerate, Egypt.
    Mahrous S; Mangoud A; Eissa M; Sabee E; Amin I; Ismail A; Morsy T; Afefy A; el-Shorbagy E; Nour Eldin E; Mostafa Y; Abouel-Magd Y; el-Sadawy M; Ragab H; Hassan M; Lakouz K; Abdel-Aziz K; Saber M; el-Hady G
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):429-46. PubMed ID: 15124751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity.
    El Aggan HA; Sidkey F; El Gezery DA; Ghoneim E
    Egypt J Immunol; 2004; 11(2):71-9. PubMed ID: 16734119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection acquired in childhood.
    Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
    Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of non-organ-specific autoantibodies in a rural community from northeastern Brazil: a population-based study.
    Cunha LM; Bittencourt PL; Abrantes-Lemos CP; Moreira A; Almeida D; Parana R; Andrade Z
    Hum Immunol; 2012 Jan; 73(1):70-4. PubMed ID: 22027387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological disorders in patients with chronic viral hepatitis type C].
    Jabłońska J; Zabek J; Kozłowska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):459-64. PubMed ID: 11921732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection.
    Siagris D; Giannakoulas N; Christofidou M; Tsamandas A; Lekkou A; Thomopoulos K; Zoumbos N; Labropoulou-Karatza Ch
    Liver Int; 2004 Jun; 24(3):204-9. PubMed ID: 15189270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up.
    Atzeni F; Doria A; Ghirardello A; Villalta D; Zampieri S; Carrabba M; Sarzi-Puttini P
    Autoimmunity; 2008 Feb; 41(1):87-91. PubMed ID: 18176869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of autoimmune markers in hepatitis C infection.
    Agarwal N; Handa R; Acharya SK; Wali JP; Dinda AK; Aggarwal P
    Indian J Med Res; 2001 May; 113():170-4. PubMed ID: 11968950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
    Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
    Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
    Ramos-Casals M; Sánchez-Tapias JM; Parés A; Forns X; Brito-Zerón P; Nardi N; Vazquez P; Vélez D; Arias I; Bové A; Plaza J; Rodés J; Font J
    J Rheumatol; 2006 Aug; 33(8):1593-9. PubMed ID: 16881116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
    Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M; Syoji S; Miyake K; Yamanaka M
    Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of autoantibodies in a Tunisian cohort of hepatitis C virus infected dialysis patients.
    Sfar I; Elbeldi A; Aouini S; Chiha A; Aouadi H; Ayed-Jendoubi S; Abderrahim E; Ben Abdallah T; Kheder A; Ayed K; Gorgi Y
    Arch Inst Pasteur Tunis; 2009; 86(1-4):63-8. PubMed ID: 20707221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.